IL6 and neoplasm: RFA has a strong catabolic effect on tumor cells that are producing nerve-stimulating cytokines such as tumor necrosis factor-alpha (TNF-α), interleukins (IL-1 and IL-6), resulting in inhibition of osteoclast activity.